OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
NRF2 Enables EGFR Signaling in Melanoma Cells
Julia Katharina Charlotte Kreß, Christina Jessen, André Marquardt, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3803-3803
Open Access | Times Cited: 22
Julia Katharina Charlotte Kreß, Christina Jessen, André Marquardt, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3803-3803
Open Access | Times Cited: 22
Showing 22 citing articles:
The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2
Julia Katharina Charlotte Kreß, Christina Jessen, Anita Hufnagel, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112724-112724
Open Access | Times Cited: 56
Julia Katharina Charlotte Kreß, Christina Jessen, Anita Hufnagel, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112724-112724
Open Access | Times Cited: 56
miRNAs as potential game-changers in melanoma: A comprehensive review
Gamil M. Abd‐Allah, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154424-154424
Closed Access | Times Cited: 54
Gamil M. Abd‐Allah, Ahmed Ismail, Hesham A. El-Mahdy, et al.
Pathology - Research and Practice (2023) Vol. 244, pp. 154424-154424
Closed Access | Times Cited: 54
Targeting EGFR in melanoma – The sea of possibilities to overcome drug resistance
Joanna Pastwińska, Kaja Karaś, Iwona Karwaciak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188754-188754
Open Access | Times Cited: 42
Joanna Pastwińska, Kaja Karaś, Iwona Karwaciak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188754-188754
Open Access | Times Cited: 42
The interplay of oncogenic signaling, oxidative stress and ferroptosis in cancer
Wentao Zeng, Xiaohang Long, Pu‐Ste Liu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 5, pp. 918-931
Closed Access | Times Cited: 37
Wentao Zeng, Xiaohang Long, Pu‐Ste Liu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 5, pp. 918-931
Closed Access | Times Cited: 37
RNAi-based ALOX15B silencing augments keratinocyte inflammation in vitro via EGFR/STAT1/JAK1 signalling
Megan A. Palmer, Rebecca Kirchhoff, Claudia Buerger, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Megan A. Palmer, Rebecca Kirchhoff, Claudia Buerger, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
NRF2 and Key Transcriptional Targets in Melanoma Redox Manipulation
Evan L. Carpenter, Alyssa L. Becker, Arup K. Indra
Cancers (2022) Vol. 14, Iss. 6, pp. 1531-1531
Open Access | Times Cited: 31
Evan L. Carpenter, Alyssa L. Becker, Arup K. Indra
Cancers (2022) Vol. 14, Iss. 6, pp. 1531-1531
Open Access | Times Cited: 31
Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update
Gabriele Roccuzzo, Eleonora Bongiovanni, Luca Tonella, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 49-66
Closed Access | Times Cited: 7
Gabriele Roccuzzo, Eleonora Bongiovanni, Luca Tonella, et al.
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 1-2, pp. 49-66
Closed Access | Times Cited: 7
The dual role of Nrf2 in melanoma: a systematic review
Zahra Malakoutikhah, Zahra Mohajeri, Nasim Dana, et al.
BMC Molecular and Cell Biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Zahra Malakoutikhah, Zahra Mohajeri, Nasim Dana, et al.
BMC Molecular and Cell Biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Cytotoxic and Antioxidant Activity of Hypericum perforatum L. Extracts against Human Melanoma Cells from Different Stages of Cancer Progression, Cultured under Normoxia and Hypoxia
Aleksandra Brankiewicz, Sara Trzos, Magdalena Mrożek, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1509-1509
Open Access | Times Cited: 13
Aleksandra Brankiewicz, Sara Trzos, Magdalena Mrożek, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1509-1509
Open Access | Times Cited: 13
EGF-induced P-gp expression in tumor vasculature contributes to therapeutic resistance to Doxorubicin-PEG-liposomes in mice bearing Doxorubicin-resistant B16-BL6 tumors
Masato Maruyama, Tomoki Ueda, Yusuke Ienaka, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106690-106690
Closed Access
Masato Maruyama, Tomoki Ueda, Yusuke Ienaka, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106690-106690
Closed Access
EGFR influences the resistance to targeted therapy in BRAF V600E melanomas by regulating the ferroptosis process
Yuexin Sun, Haoyue Yu, Ying Zhou, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Yuexin Sun, Haoyue Yu, Ying Zhou, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Open Access
Design and synthesis of novel 2-S-alkylated Quinazolinones as dual BRAFV600E and EGFR inhibitors in melanoma: Mechanistic insights from apoptosis and cell cycle modulation
Hamed W. El-Shafey, Mohammad M. Al‐Sanea, Mohamed R. Elnagar, et al.
Bioorganic Chemistry (2025), pp. 108526-108526
Closed Access
Hamed W. El-Shafey, Mohammad M. Al‐Sanea, Mohamed R. Elnagar, et al.
Bioorganic Chemistry (2025), pp. 108526-108526
Closed Access
The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19
Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7963-7963
Open Access | Times Cited: 21
Sonia Emanuele, Adriana Celesia, Antonella D’Anneo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7963-7963
Open Access | Times Cited: 21
Nrf2 protein in melanoma progression, as a new means of treatment
Qun Feng, Xiaolin Xu, S Zhang
Pigment Cell & Melanoma Research (2023) Vol. 37, Iss. 2, pp. 247-258
Open Access | Times Cited: 7
Qun Feng, Xiaolin Xu, S Zhang
Pigment Cell & Melanoma Research (2023) Vol. 37, Iss. 2, pp. 247-258
Open Access | Times Cited: 7
Aloysia Citrodora Essential Oil Inhibits Melanoma Cell Growth and Migration by Targeting HB-EGF-EGFR Signaling
Yousef Salama, Nidal Jaradat, Koichi Hattori, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8151-8151
Open Access | Times Cited: 16
Yousef Salama, Nidal Jaradat, Koichi Hattori, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8151-8151
Open Access | Times Cited: 16
The Role of Protein SUMOylation in Human Hepatocellular Carcinoma: A Potential Target of New Drug Discovery and Development
Hongchao Yuan, Yuanjun Lu, Yau-Tuen Chan, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5700-5700
Open Access | Times Cited: 16
Hongchao Yuan, Yuanjun Lu, Yau-Tuen Chan, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5700-5700
Open Access | Times Cited: 16
Momordica cochinchinensis (Gấc) Seed Extracts Induce Apoptosis and Necrosis in Melanoma Cells
Dao Nguyen, Jessica K. Holien, Chaitali Dekiwadia, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 100-100
Open Access | Times Cited: 6
Dao Nguyen, Jessica K. Holien, Chaitali Dekiwadia, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 1, pp. 100-100
Open Access | Times Cited: 6
Thiol starvation triggers melanoma state switching in an ATF4 and NRF2-dependent manner
Madlen Meinert, Christina Jessen, Anita Hufnagel, et al.
Redox Biology (2023) Vol. 70, pp. 103011-103011
Open Access | Times Cited: 6
Madlen Meinert, Christina Jessen, Anita Hufnagel, et al.
Redox Biology (2023) Vol. 70, pp. 103011-103011
Open Access | Times Cited: 6
Proteomic Changes in the Monolayer and Spheroid Melanoma Cell Models of Acquired Resistance to BRAF and MEK1/2 Inhibitors
Ramón Martínez, Weiliang Huang, Heather V. Buck, et al.
ACS Omega (2022) Vol. 7, Iss. 4, pp. 3293-3311
Open Access | Times Cited: 8
Ramón Martínez, Weiliang Huang, Heather V. Buck, et al.
ACS Omega (2022) Vol. 7, Iss. 4, pp. 3293-3311
Open Access | Times Cited: 8
Targeting protein kinases benefits cancer immunotherapy
Zhengkun Zhang, Lang Bu, Junhang Luo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188738-188738
Closed Access | Times Cited: 8
Zhengkun Zhang, Lang Bu, Junhang Luo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 4, pp. 188738-188738
Closed Access | Times Cited: 8
NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma
Shuming Hu, Yuan Yuan, Ruihan Yan, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 708, pp. 149798-149798
Closed Access
Shuming Hu, Yuan Yuan, Ruihan Yan, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 708, pp. 149798-149798
Closed Access
Silencing Nrf2 in cisplatin resistant non-small cell lung cancer cells augments sensitivity towards EGFR inhibitor
Chandrani Fouzder, Alpana Mukhuty, Dipanjan Chattopadhyay, et al.
Toxicology in Vitro (2024) Vol. 101, pp. 105921-105921
Closed Access
Chandrani Fouzder, Alpana Mukhuty, Dipanjan Chattopadhyay, et al.
Toxicology in Vitro (2024) Vol. 101, pp. 105921-105921
Closed Access
Kelch-like ECH-associated Protein 1/Nuclear Factor Erythroid 2-related Factor 2 Pathway and Its Interplay with Oncogenes in Lung Tumorigenesis
Taegeun Bae, Mi‐Kyoung Kwak
Journal of Cancer Prevention (2024) Vol. 29, Iss. 4, pp. 89-98
Open Access
Taegeun Bae, Mi‐Kyoung Kwak
Journal of Cancer Prevention (2024) Vol. 29, Iss. 4, pp. 89-98
Open Access
